Characteristic Number of patients (per cent) Number of Deaths (per cent)
Gender Male 418(44.9) 179(42.82)
Female 512(55.1) 187(36.52)
Age (Year) 15-24 94(10.1) 35(37.23)
25-34 375(40.3) 142(37.87)
35-44 304(32.7) 121(39.8)
45+ 157(16.9) 68(43.31)
WHO clinical stage Stage I and II 116(12.5) 34(29.31)
Stage III 699(75.2) 261(37.34)
Stage IV 115(12.4) 71(61.74
Regimen Stavudine 348(37.4) 132(37.93)
Zidovudine 516(55.5) 225(43.6)
Marital status Unmarried 118(12.7) 48(40.68)
Married 387(41.6) 145(37.47)
Separated 425(45.7) 173(40.71)
Education* Illiterate 290(31.7) 106(36.55)
Primary 309(33.2) 129(41.75)
Secondary+ 322(34.6) 128(39.75)
Occupation * Employed 206(22.2) 77(37.38)
Unemployed 606(65.2) 250(41.25)
Residence* Urban 673(72.4) 257(38.19)
Rural 242(26.0) 102(42.15)
CTX prophylaxis* Yes 554(59.6) 194(35.02
No 278(29.9) 133(47.84
Adherence * Good 648(69.7) 168(25.93
Poor 191(20.5) 131(68.59
Baseline functional status Working 538(57.8) 154(28.62
Ambulatory 324(34.8) 164(50.62
Bedridden 68(7.3) 48(70.59
Anemia * No 430(46.2) 84(19.53
Mild 259(27.8) 116(44.79
Mod to Severe 144(15.5) 102(70.83
CD4 count (cells/ml) ≥200 95(10.2) 20(21.05
100-199 428(46.0) 132(30.84
50-99 212(22.8) 96(45.28)
<50 195(21.0) 118(60.51)
Table 1: Baseline characteristics and associated mortality among 930 HIV-infected patients starting ART at Debre Markos Hospital, 2012.